These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 31925628)

  • 1. Annexin-A5 resistance and non-criteria antibodies for the diagnosis of seronegative antiphospholipid syndrome.
    Ferreira TG; Delhommeau F; Johanet C; Gerotziafas G; Bornes M; Cohen J; Kayem G; Fain O; Planche V; Mékinian A
    Clin Rheumatol; 2020 Apr; 39(4):1167-1171. PubMed ID: 31925628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody-positive patients with adverse clinical outcomes.
    Wolgast LR; Arslan AA; Wu XX; Beyda JN; Pengo V; Rand JH
    J Thromb Haemost; 2017 Jul; 15(7):1412-1421. PubMed ID: 28393472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Diagnostic Value of New Additional Antiphospholipid Antibodies in Antiphospholipid Syndrome.
    Khogeer H; Altahan S; Alrehaily A; Sheikh A; Awartani K; Al-Kaff M; Saleh S; Alzahrani H; Alfattani A; Owaidah T
    Ann Clin Lab Sci; 2021 Jul; 51(4):552-556. PubMed ID: 34452895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prevalence of antiannexin A5 antibodies in unprovoked venous thrombosis.
    Ho WK; Rigano J
    Int J Lab Hematol; 2021 Oct; 43(5):1225-1228. PubMed ID: 33586909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
    Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA
    Front Immunol; 2018; 9():2971. PubMed ID: 30619328
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-conventional antiphospholipid antibodies in patients with clinical obstetrical APS: Prevalence and treatment efficacy in pregnancies.
    Mekinian A; Bourrienne MC; Carbillon L; Benbara A; Noémie A; Chollet-Martin S; Tigaizin A; Montestruc F; Fain O; Nicaise-Roland P
    Semin Arthritis Rheum; 2016 Oct; 46(2):232-237. PubMed ID: 27432776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncriteria antiphospholipid antibodies in antiphospholipid syndrome.
    Devreese KMJ
    Int J Lab Hematol; 2024 May; 46 Suppl 1():34-42. PubMed ID: 38584293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Non-criteria" antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort.
    Liu T; Gu J; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Zhou J; Norman GL; Wang X; Yang C; Shi H
    Arthritis Res Ther; 2020 Feb; 22(1):33. PubMed ID: 32085759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome.
    Zhang S; Wu Z; Li J; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
    Clin Rheumatol; 2017 Feb; 36(2):407-412. PubMed ID: 28000012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Non-criteria antiphospholipid antibodies': bridging the gap between seropositive and seronegative antiphospholipid syndrome.
    Truglia S; Mancuso S; Capozzi A; Recalchi S; Riitano G; Longo A; De Carolis S; Spinelli FR; Alessandri C; Ceccarelli F; De Carolis C; Misasi R; Sorice M; Conti F
    Rheumatology (Oxford); 2022 Feb; 61(2):826-833. PubMed ID: 33970223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
    Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of annexin A5 resistance in children and adolescents with rheumatic diseases.
    Wahezi DM; Ilowite NT; Rajpathak S; Rand JH
    J Rheumatol; 2012 Feb; 39(2):382-8. PubMed ID: 22174207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Diagnostic Value of Non-criteria Antibodies for Antiphospholipid Syndrome Patients in a Chinese Cohort.
    Hu C; Li S; Xie Z; You H; Jiang H; Shi Y; Qi W; Zhao J; Wang Q; Tian X; Li M; Zhao Y; Zeng X
    Front Immunol; 2021; 12():741369. PubMed ID: 34567005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome.
    Bećarević M; Sarić M; Stojanovich L; Mirković D; Dopsaj V; Ignjatović S
    Clin Rheumatol; 2018 Dec; 37(12):3359-3364. PubMed ID: 29948348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IgM isotype of anti-annexin A5 antibodies and multiple positivity of conventional antiphospholipid antibodies: increasing the number of clinical manifestations of primary antiphospholipid syndrome.
    Bećarević M; Stojanović L; Ignjatović S; Dopsaj V
    Clin Rheumatol; 2016 May; 35(5):1361-5. PubMed ID: 26971791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IgG and IgM isotypes of anti-annexin A5 antibodies: relevance for primary antiphospholipid syndrome.
    Bećarević M
    J Thromb Thrombolysis; 2016 Nov; 42(4):552-7. PubMed ID: 27307251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome.
    Zhang S; Wu Z; Zhang W; Zhao J; Norman GL; Zeng X; Zhang F; Li Y
    Clin Chem Lab Med; 2018 May; 56(6):939-946. PubMed ID: 29561729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetrical outcome and treatments in seronegative primary APS: data from European retrospective study.
    Abisror N; Nguyen Y; Marozio L; Esteve Valverde E; Udry S; Pleguezuelo DE; Billoir P; Mayer-Pickel K; Urbanski G; Zigon P; De Moreuil C; Hoxha A; Bezanahary H; Carbillon L; Kayem G; Bornes M; Yelnik C; Johanet C; Nicaise-Roland P; Lambert M; Salle V; Latino OJ; Hachulla E; Benedetto C; Bourrienne MC; Benhamou Y; Alijotas-Reig J; Fain O; Mekinian A;
    RMD Open; 2020 Aug; 6(2):0. PubMed ID: 32848089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
    Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
    Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.